A Meta-Analysis of Brain-Derived Neurotrophic Factor Effects on Brain Volume in Schizophrenia: Genotype and Serum Levels

Abstract

Aim: The Val66Met single-nucleotide polymorphism (SNP) on the BDNF gene has established pleiotropic effects on schizophrenia incidence and morphologic alterations in the illness. The effects of brain-derived neurotrophic factor (BDNF) on brain volume measurements are however mixed seeming to be less established for most brain regions. The current meta-analytic review examined (1) the association of the Val66Met SNP and brain volume alterations in schizophrenia by comparing Met allele carriers to Val/Val homozygotes and (2) the association of serum BDNF with brain volume measurements. Method: Studies included in the meta-analyses were identified through an electronic search of PubMed and PsycInfo (via EBSCO) for English language publications from January 2000 through December 2017. Included studies had conducted a genotyping procedure of Val66Met or obtained assays of serum BDNF and obtained brain volume data in patients with psychotic disorders. Nonhuman studies were excluded. Results: Study 1 which included 52 comparisons of Met carriers and Val/Val homozygotes found evidence of lower right and left hippocampal volumes among Met allele carriers with schizophrenia. Frontal measurements, while also lower among Met carriers, did not achieve statistical significance. Study 2 which included 7 examinations of the correlation between serum BDNF and brain volume found significant associations between serum BDNF levels and right and left hippocampal volume with lower BDNF corresponding to lower volumes. Discussion: The meta-analyses provided evidence of associations between brain volume alterations in schizophrenia and variations on the Val66Met SNP and serum BDNF. Given the limited number of studies, it remains unclear if BDNF effects are global or regionally specific.

Frontotemporal Transcranial Direct Current Stimulation Decreases Serum Mature Brain-Derived Neurotrophic Factor in Schizophrenia

“…Thus, NIBS may either increase, decrease, or have no effect on peripheral BDNF levels depending on NIBS parameters and on the diagnosis of participants. To the best of our knowledge, no previous study has investigated the effects of tDCS on BDNF levels in patients with schizophrenia, although some evidence suggests abnormal BDNF regulation in this illness [43,44]. The present findings suggest that a single session of frontotemporal tDCS may decrease mBDNF in patients with schizophrenia and treatment-resistant AVH.…”

Neuronavigated Repetitive Transcranial Stimulation Improves Neurocognitive Functioning in Veterans with Schizophrenia: A Possible Role of BDNF Polymorphism

“…BDNF is encoded by the BDNF gene, which is located on chromosome 11 at the boundary of 11p13 and 11p14 in the human [ 32 ]. More than one hundred polymorphisms in the BDNF gene have been identified and previous evidence has pointed to some specific SNPs and positive associations with the cognitive impairments in SZ [ 33 , 34 ]. For example, evidence supports that hippocampus-dependent learning and declarative memory is influenced by the BDNF Val66Met (rs6265) variant [ 35 ].…”

Relationship between thyroid-stimulating hormone, BDNF levels, and hippocampal volume in antipsychotic-naïve first-episode psychosis patients

“…BDNF is also involved in the etiopathogenesis of several psychiatric disorders ( 16 , 17 ), including psychotic disorders ( 18 ). Furthermore, an association between BDNF and hippocampal volume in schizophrenia and FEP has been well documented ( 19 ).…”